20 June 2014
The Development of Novel Biologics and Serosurveillance Studies of Emerging and Zoonotic Viruses
Organised by:
SCI's Biotechnology Group in conjunction with the University of Westminster
University of Westminster, 115 New Cavendish Street, London W1W 6UW
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
The study of highly pathogenic viruses is limited by the need for biosafety level 3 or 4 laboratories to handle wild type viruses. Using pseudotyping technology overcomes this and also has several other advantages over using wild type virus. We successfully pseudotyped isolates from each lyssavirus species allowing us to study the antigenic properties of the viral glycoproteins, develop novel therapeutics against the protoype species, rabies virus, and undertake serosurveillence studies to further our understanding of the public health threat these viruses pose. We are currently expanding this technology to include other emerging, zoonotic viruses.Programme
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Venue and Contact
University of Westminster
School of Life Sciences,115 New Cavendish Street London W1W 6UW
Conference Team
Email: Communications@soci.org
Fees
This is a free event, no need to book.
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Partners
